I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.71 USD -6.56% Market Closed
Market Cap: 50.7m USD
Have any thoughts about
Immuneering Corp?
Write Note

Immuneering Corp
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Immuneering Corp
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
I
Immuneering Corp
NASDAQ:IMRX
Accounts Payable
$2.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$30.5B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$18.9B
CAGR 3-Years
153%
CAGR 5-Years
80%
CAGR 10-Years
35%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$3.6B
CAGR 3-Years
205%
CAGR 5-Years
108%
CAGR 10-Years
58%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$497.3m
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
27%

See Also

What is Immuneering Corp's Accounts Payable?
Accounts Payable
2.1m USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Accounts Payable amounts to 2.1m USD.

What is Immuneering Corp's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
12%

Over the last year, the Accounts Payable growth was -34%. The average annual Accounts Payable growth rates for Immuneering Corp have been 12% over the past three years .

Back to Top